In cases where sites express divergent developmental trajectories, they discuss how subtle and even seemingly benign differences between the pre-disturbance and post-disturbance environments can lead to starkly different ecological outcomes, with emphasis on potential mechanisms of ecological divergence.
Benign Differences The latest findings make it clear that mosaicism is quite common — even in healthy cells.
Tolerance may seem like a good policy where benign differences between cultures are concerned, but it does not seem so when, for example, a society engages in officially approved genocide, even within its own borders.
While our data showed that CI was more frequent in benign treatments, this difference was not attributed to weaker selection.
Syndecan-1 and osteopontin levels were both significantly higher in malignant pleural effusions than in those with benign conditions, the difference being more pronounced with syndecan-1.
The key characteristic of a fan-shaped interaction is that, in benign environments, the difference in the level of the outcome variable (i.e., Y) as a function of the level of genetic liability is quite modest.
Despite a lower cumulative incidence rate for species 10 (benign types), the difference was not statistically significant when compared to species 7 and 9 (log-rank test; p = 0.892).
Vascular flow examination in malignant, borderline and benign tumors showed differences between these tumor types, with respective gradual lowering of RI and PI values [ 22].
Differences may be related with the fact that a group of Prof. Klopfleisch examined general differences between benign and malignant tumors, whereas we have analyzed specific differences between various grades of canine mammary malignancy.
This difference between benign and malignant tumors is supported by another study performed by our group, where we analysed benign and malignant samples using SELDI-TOF MS [ 2].
The concern, however, is that since doctors do not yet have a clear way to tell the difference between benign or slow-growing tumors and aggressive diseases with many of these conditions, they treat everything as if it might become aggressive.
